Skip to main content

Table 3 Predicted mammographic measures in women 60 and 70 years old by pattern of menopausal hormone therapy use

From: Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study

 

PMD (%)

DA (cm2)

NDA (cm2)

Predicted (95% CI)

Predicted (95% CI)

Predicted (95% CI)

For women aged 60 years

 Never

24 (22 to 26)

24 (22 to 26)

78 (72 to 83)

 Current

33 (31 to 35)

33 (31 to 35)

67 (63 to 70)

 Past, 0–2 years since last use

32 (29 to 36)

33 (29 to 37)

67 (60 to 74)

 Past, > 2 years since last use

26 (24 to 29)

25 (23 to 28)

74 (68 to 81)

For women aged 70 years

 Never

20 (18 to 23)

24 (21 to 27)

94 (86 to 101)

 Current

29 (26 to 32)

33 (30 to 37)

82 (75 to 89)

 Past, 0–2 years since last use

28 (24 to 32)

33 (29 to 38)

81 (73 to 91)

 Past, > 2 years since last use

23 (20 to 26)

26 (23 to 29)

90 (82 to 98)

  1. PMD percent mammographic density, DA dense area, NDA non-dense area